This product belongs to the benzimidazole class of antiparasitic agents and is used for the treatment of various helminth infections. Its mechanism of action involves disruption of parasite energy metabolism, inhibition of microtubule synthesis, and impairment of glucose uptake, leading to parasite death and elimination.
Recommended for:
Fenbendazole has been extensively studied in parasitology research. Scientific data and clinical observations demonstrate its effectiveness and acceptable safety profile when used as directed. Studies indicate that fenbendazole affects multiple stages of the parasite life cycle, which contributes to reliable therapeutic outcomes and reduced recurrence rates.
Indicated for the treatment of parasitic infections caused by helminths sensitive to fenbendazole. Used to eliminate parasites, reduce associated symptoms, and support recovery of normal gastrointestinal function by inhibiting essential cellular processes in parasites.
Administered orally, usually with or after meals. The dosage regimen and duration of therapy should be determined by a healthcare professional based on the type of infection and patient condition.
Contraindications
Side Effects
